Role of yeast glutaredoxins as glutathione S-transferases [PMID: 12684511] Laboratory literature summary: Role of yeast glutaredoxins as glutathione S-transferases
Zhang, J., Zhao, Y., Ren, D., & Yang, X
Third-generation EGFR inhibitors, including osimertinib, have demonstrated efficacy against T790M-positive disease in phase III clinical trials, while newer ALK and ROS1 inhibitors have been developed to overcome solvent-front mutations
This transgenic mouse overexpresses the human amyloid precursor protein (APP) carrying two familial AD mutations: The Swedish mutation (KM670/671NL), which increases total A production by enhancing -secretase cleavage, and the Indiana mutation (V717F), which alters -secretase cleavage to favor production of the more aggregation-prone amyloid-beta 142 peptide (A 142 ) [464467]
This entire process depends on adequate gastric acid, proper enzyme secretion, and appropriate transit time through the GI tract